Financhill
Back

Corcept Therapeutics Quote, Financials, Valuation and Earnings

Your bank account could be compromised

Follow these three simple steps to protect your savings now.
Buy
70

CORT
Corcept Therapeutics

Last Price:
31.56
Seasonality Move:
5.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Corcept Therapeutics Price Quote

$31.56
+0.39 (+1.25%)
(Updated: July 12, 2024 at 1:50 PM ET)

Corcept Therapeutics Key Stats

Buy
70
Corcept Therapeutics (CORT) is a Buy

Day range:
$30.77 - $31.60
52-week range:
$20.84 - $35.22
Dividend yield:
0%
P/E ratio:
33.16
P/S ratio:
6.57
P/B ratio:
5.92%

Volume:
565K
Avg. volume:
1.1M
1-year change:
38.16%
Market cap:
$3.2B
Revenue:
$482.4M
EPS:
$1.06

How Much Does Corcept Therapeutics Make?

Is Corcept Therapeutics Growing As A Company?

  • What Is Corcept Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.39%
  • What Is Corcept Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.79%

Corcept Therapeutics Stock Price Performance

What Is Corcept Therapeutics 52-Week High & Low?

Corcept Therapeutics Price To Free Cash Flow

Is It Risky To Buy Corcept Therapeutics?

Is Corcept Therapeutics Cash Flow Positive?

  • What Is CORT Cash Flow From Operations?
    Cash flow from operations (TTM) is $124.8M
  • What Is Corcept Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$149.4M
  • What Is Corcept Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$125.6M

Corcept Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CORT return on invested capital is 23.92%
  • What Is Corcept Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 19.58%
  • What Is CORT Return On Equity?
    ROE is a measure of profitability and is 23.92%

Corcept Therapeutics Earnings Date & Stock Price

Corcept Therapeutics Competitors

  • Who Are Corcept Therapeutics's Competitors?
    Below is a list of companies who compete with Corcept Therapeutics or are related in some way:
    • Ligand Pharmaceuticals Inc (LGND)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Warby Parker Inc (WRBY)

Corcept Therapeutics Dividend Yield

Data Unavailable

Corcept Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 78.57% 13.64%
Revenue: 38.95% 3.97%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 49.70
Upside from Last Price: 59.45%

Major Shareholders

  • How many CORT shares are owned by institutional investors?
    134.1M CORT shares are owned by institutional investors
  • How many CORT shares are owned by insiders?
    8.3M CORT shares are owned by insiders